Business Wire

SPIE and Boston University Announce $1-Million Endowment for Graduate and Postgraduate Scholarships

27.1.2025 06:03:00 CET | Business Wire | Press Release

Share

SPIE, the international society for optics and photonics, and Boston University (BU) announced the establishment of the SPIE-Boston University Scholarship in Photonics during SPIE Photonics West in San Francisco. The $500,000 gift from SPIE will be matched 100% by BU. Part of the SPIE Endowment Matching Program, this new endowment will support annual scholarships for BU students pursuing research in photonics at the Boston University Photonics Center. This is the 12th major SPIE gift to universities and institutes as part of the Society's ongoing program to support the international expansion of optics and photonics through increased educational capacity, funding of research, and the development of talent pipelines for industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250124384289/en/

Boston University College of Engineering Associate Professor Jerry Chen, center, with senior scientist Andrew Blaeser to the left, and former undergraduate research assistant Rhea Singh to the right, working with a Quadroscope, a custom, two-photon mesoscope. Credit: Christopher McIntosh.

The new annual scholarships will be available for up to two graduate students or one postdoctoral researcher at the Boston University Photonics Center, who are exploring impactful areas of photonics research. Application of funds will include coverage of each recipient’s stipend, health benefits, and travel costs to present their work at an SPIE conference.

“We are enormously grateful for the opportunity to partner with SPIE in this endowment program to support graduate and post-graduate research scholarship at the frontiers of optics and photonics,” said Photonics Center Director and Vice President and Associate Provost ad interim for Research Dr. Thomas Bifano. “The Boston University Photonics Center has a long and proud history of collaboration with SPIE, including the sponsorship of SPIE events and an SPIE student chapter. Creation of this endowed fund will advance our shared commitment with SPIE to help train and support future leaders in the societally important fields of optics and photonics.”

“The SPIE-Boston University Scholarship in Photonics offers critical support for the future of photonics,” said SPIE CEO Kent Rochford. “By supporting the education of photonics researchers as well as potential photonics industry leaders, the SPIE-Boston University Scholarship in Photonics will have an ongoing impact on the field for generations to come, and we are delighted to partner with the university on this enterprising venture.”

The SPIE Endowment Matching Program was established in 2019 to increase international capacity in the teaching and research of optics and photonics. With this latest gift, SPIE has provided over $4.5 million in matching gifts, resulting in more than $12 million in dedicated funds. The SPIE Endowment Matching Program supports optics and photonics education and the future of the industry by contributing a match of up to $500,000 per award to college, institute, and university programs with optics and photonics degrees, or with other disciplines allied to the SPIE mission. Proposals for the next round of consideration are currently being accepted, and are due 30 April.

About Boston University and the Boston University Photonics Center

Boston University is an international, comprehensive, private research university, committed to educating students to be reflective, resourceful individuals ready to live, adapt, and lead in an interconnected world. Boston University is committed to generating new knowledge to benefit society. The Boston University Photonics Center generates fundamental knowledge and develops innovative technology in the field of photonics. We work on challenging problems that are important to society, we translate enabling research discoveries into useful prototypes, and we educate future leaders in the field.

About SPIE

SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, we have invested more than $25 million in the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250124384289/en/

Contacts

Cara Ellis McCarthy
Executive Director, Boston University Photonics Center
+1 (617) 358 4257
cellis@bu.edu

Daneet Steffens
Public Relations Manager, SPIE
daneets@spie.org
+1 360 685 5478
@spie.org -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbsky.app%2Fpro
file%2Fspie.org&esheet=54190111&newsitemid=20250124384289&lan=en-US&anchor=%40sp
ie.org&index=5&md5=1e2aef807638cdf377dc518e1170c4c1

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-

Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press Release

A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of

TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press Release

Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the

Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press Release

Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan

Grindr Nominates Three New Directors to Its Board of Directors30.4.2026 23:16:00 CEST | Press Release

Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye